Risk factors associated with sub-optimal outcomes and hematotoxicity following obecabtagene autoleucel (obe-cel) for relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) Meeting Abstract


Authors: Sandhu, K. S.; Park, J. H.; Shaughnessy, P.; Logan, A. C.; Abedi, M.; Shah, B.; Bishop, M. R.; Deangelo, D. J.; Brugger, W.; Shang, J.; Jabbour, E.; Roddie, C.
Abstract Title: Risk factors associated with sub-optimal outcomes and hematotoxicity following obecabtagene autoleucel (obe-cel) for relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL)
Meeting Title: 2025 Tandem Meetings of ASTCT and CIBMTR
Journal Title: Transplantation and Cellular Therapy
Volume: 31
Issue: 2 Suppl.
Meeting Dates: 2025 Feb 12-15
Meeting Location: Honolulu, HI
ISSN: 2666-6375
Publisher: Elsevier Inc.  
Date Published: 2025-02-01
Start Page: S7
Language: English
ACCESSION: WOS:001441170700009
PROVIDER: wos
DOI: 10.1016/j.jtct.2025.01.016
Notes: Meeting Abstract: 10 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jae Hong Park
    356 Park